FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079521830> ?p ?o ?g. }

• W2079521830 endingPage "5310" @default.
• W2079521830 startingPage "5291" @default.
• W2079521830 abstract "This paper describes the implementation of a biochemical and biophysical screening strategy to identify and optimize small molecule Akt1 inhibitors that act through a mechanism distinct from that observed for kinase domain ATP-competitive inhibitors. With the aid of an unphosphorylated Akt1 cocrystal structure of 12j solved at 2.25 Å, it was possible to confirm that as a consequence of binding these novel inhibitors, the ATP binding cleft contained a number of hydrophobic residues that occlude ATP binding as expected. These Akt inhibitors potently inhibit intracellular Akt activation and its downstream target (PRAS40) in vitro. In vivo pharmacodynamic and pharmacokinetic studies with two examples, 12e and 12j, showed the series to be similarly effective at inhibiting the activation of Akt and an additional downstream effector (p70S6) following oral dosing in mice." @default.
• W2079521830 created "2016-06-24" @default.
• W2079521830 creator A5000438750 @default.
• W2079521830 creator A5001292543 @default.
• W2079521830 creator A5007296799 @default.
• W2079521830 creator A5007582656 @default.
• W2079521830 creator A5012865694 @default.
• W2079521830 creator A5015240127 @default.
• W2079521830 creator A5022706760 @default.
• W2079521830 creator A5028549254 @default.
• W2079521830 creator A5029374868 @default.
• W2079521830 creator A5032257574 @default.
• W2079521830 creator A5033844108 @default.
• W2079521830 creator A5039580026 @default.
• W2079521830 creator A5039793104 @default.
• W2079521830 creator A5041253361 @default.
• W2079521830 creator A5045127959 @default.
• W2079521830 creator A5047957593 @default.
• W2079521830 creator A5049580373 @default.
• W2079521830 creator A5052292949 @default.
• W2079521830 creator A5052476069 @default.
• W2079521830 creator A5053232883 @default.
• W2079521830 creator A5057399487 @default.
• W2079521830 creator A5058333660 @default.
• W2079521830 creator A5061753526 @default.
• W2079521830 creator A5063166319 @default.
• W2079521830 creator A5063341697 @default.
• W2079521830 creator A5068591144 @default.
• W2079521830 creator A5069088532 @default.
• W2079521830 creator A5069841640 @default.
• W2079521830 creator A5083078738 @default.
• W2079521830 creator A5083394481 @default.
• W2079521830 creator A5083788661 @default.
• W2079521830 date "2012-05-31" @default.
• W2079521830 modified "2023-10-16" @default.
• W2079521830 title "Discovery and Optimization of a Series of 3-(3-Phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors" @default.
• W2079521830 cites W1964407556 @default.
• W2079521830 cites W1981711832 @default.
• W2079521830 cites W2009364489 @default.
• W2079521830 cites W2012169430 @default.
• W2079521830 cites W2027161653 @default.
• W2079521830 cites W2027731629 @default.
• W2079521830 cites W2047132220 @default.
• W2079521830 cites W2047470069 @default.
• W2079521830 cites W2054683873 @default.
• W2079521830 cites W2063013228 @default.
• W2079521830 cites W2063689857 @default.
• W2079521830 cites W2070643112 @default.
• W2079521830 cites W2076228503 @default.
• W2079521830 cites W2079029484 @default.
• W2079521830 cites W2082036439 @default.
• W2079521830 cites W2112842133 @default.
• W2079521830 cites W2150026213 @default.
• W2079521830 cites W2159750196 @default.
• W2079521830 cites W2162103271 @default.
• W2079521830 cites W2177206102 @default.
• W2079521830 doi "https://doi.org/10.1021/jm300276x" @default.
• W2079521830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22533986" @default.
• W2079521830 hasPublicationYear "2012" @default.
• W2079521830 type Work @default.
• W2079521830 sameAs 2079521830 @default.
• W2079521830 citedByCount "61" @default.
• W2079521830 countsByYear W20795218302012 @default.
• W2079521830 countsByYear W20795218302013 @default.
• W2079521830 countsByYear W20795218302014 @default.
• W2079521830 countsByYear W20795218302015 @default.
• W2079521830 countsByYear W20795218302016 @default.
• W2079521830 countsByYear W20795218302017 @default.
• W2079521830 countsByYear W20795218302018 @default.
• W2079521830 countsByYear W20795218302019 @default.
• W2079521830 countsByYear W20795218302020 @default.
• W2079521830 countsByYear W20795218302021 @default.
• W2079521830 countsByYear W20795218302022 @default.
• W2079521830 countsByYear W20795218302023 @default.
• W2079521830 crossrefType "journal-article" @default.
• W2079521830 hasAuthorship W2079521830A5000438750 @default.
• W2079521830 hasAuthorship W2079521830A5001292543 @default.
• W2079521830 hasAuthorship W2079521830A5007296799 @default.
• W2079521830 hasAuthorship W2079521830A5007582656 @default.
• W2079521830 hasAuthorship W2079521830A5012865694 @default.
• W2079521830 hasAuthorship W2079521830A5015240127 @default.
• W2079521830 hasAuthorship W2079521830A5022706760 @default.
• W2079521830 hasAuthorship W2079521830A5028549254 @default.
• W2079521830 hasAuthorship W2079521830A5029374868 @default.
• W2079521830 hasAuthorship W2079521830A5032257574 @default.
• W2079521830 hasAuthorship W2079521830A5033844108 @default.
• W2079521830 hasAuthorship W2079521830A5039580026 @default.
• W2079521830 hasAuthorship W2079521830A5039793104 @default.
• W2079521830 hasAuthorship W2079521830A5041253361 @default.
• W2079521830 hasAuthorship W2079521830A5045127959 @default.
• W2079521830 hasAuthorship W2079521830A5047957593 @default.
• W2079521830 hasAuthorship W2079521830A5049580373 @default.
• W2079521830 hasAuthorship W2079521830A5052292949 @default.
• W2079521830 hasAuthorship W2079521830A5052476069 @default.
• W2079521830 hasAuthorship W2079521830A5053232883 @default.
• W2079521830 hasAuthorship W2079521830A5057399487 @default.
• W2079521830 hasAuthorship W2079521830A5058333660 @default.
• W2079521830 hasAuthorship W2079521830A5061753526 @default.

• next